Araris Biotech AG
Araris Biotech AG, a wholly owned subsidiary of Taiho Pharma, is pioneering a novel linker technology enabling fast and precise production of stable ADCs with an improved therapeutic index. Our innovative approach has the potential to set new benchmarks in terms of ADC performance, development and analysis.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}